Table 3.
Multivariate analysis of prognostic factors for overall survival.
| Variables | HR (95% CI) | P value |
|---|---|---|
| BCLC class | ||
| C | 1 | |
| B | 0.462 (0.325, 0.657) | 0.000 |
| A | 0.334 (0.222, 0.503) | 0.000 |
| AST (μmol/L) | 1.000 (0.999, 1.001) | 0.895 |
| PLR | 1.002 (1.000, 1.003) | 0.015 |
| NLR | 1.007 (0.985, 1.030) | 0.510 |
| Tumor size | 1.036 (1.000, 1.075) | 0.053 |
| TACE sessions | 0.698 (0.642, 0.759) | 0.000 |
| Treatment method | ||
| D-TACE + liopodol | 1 | |
| D-TACE | 2.268 (1.361, 3.779) | 0.002 |
Note. HR: hazard ratio; CI: confidence interval; BCLC: barcelona clinical liver cancer; AST: aspartate aminotransferase; PLR: platelet-to-lymphocyte ratio; NLR: neutrophil-to-lymphocyte ratio; D-TACE: drug-elutingbeads-transcatheter arterial chemoembolization.